About half of the drugs currently produced are chiral compounds, and about 90 % these compounds sold as racemates, consisting an equimolar mixture two enantiomers. Although they have same chemical structure, most optical isomers substances show marked differences in biological activity. It is known that presence a single asymmetric atom has become almost integral part advanced drug design. The ...

In the mononuclear title complex, [Pt(CH(3))Cl(C(25)H(23)N(2)P)], the N-benzyl-N-(diphenyl-phosphanylmeth-yl)pyridin-2-amine functions as a bidentate ligand with the pyridyl N atom and the phosphine P atom chelating the Pt(II) ion, forming a six-membered metallocycle. The Pt(II) atom adopts a square-planar coordination geometry with one methyl group and one chloride ligand bonding to the metal ...

Two copper complexes, 1 and 2, with tridentate N-donor ligands, L(1) and L(2) [L(1)= (1-methyl-1H-imidazol-2-ylmethyl)-(2-pyridin-2-yl-ethyl)amine, L(2) = (2-pyridin-2-yl-ethyl)-pyridin-2 yl-methylamine] respectively, have been synthesized and characterized. On exposure to nitric oxide, the copper(II) centers in complexes 1 and 2 were found to undergo reduction in various solvents. In acetonitr...

Considering various biomedical significance & with a view of pharmacological actions compound belong to this class, new series N-(substituted phenyl)-2-methyl-4-(2-(6-oxo-1-phenyl-1-6-dihydro-[2-3-bipyridin]-5-yl)phenyl)-1-4-dihydro pyrimido [1, 2-a] benzimidazole-3-carboxamide ware prepared. The formation the was accomplished by cyclocondensation 2-(1, 2-dihydro-2-oxo-1-phenyl-5-(pyridin-2...

The synthesis and characterisation of a series of dinuclear ruthenium and osmium polypyridyl metal complexes based on the bridging ligands [5-(5'-bipyridin-2',2''-yl)-3-(pyridin-2-yl)]-1,2,4-triazole (Hpytr-bipy), 2,2'-bis(pyridin-2''yl)-5,5'-bis(pyridin-3''-yl) (bipy-bipy) and 5,5'-bis(pyridin-2''-yl)-3,3'-bis(1,2,4-triazole) (Hpytr-Hpytr) are reported. The dinuclear complexes have been synthe...

The androgen receptor inhibitor, Enzalutamide, proved effective against castration resistance prostate cancer, has demonstrated clinical benefits and increased survival rate in men. However, AR mutation (F876L) converts Enzalutamide from antagonist to agonist indicating a rapid evolution of resistance. Hence, our goal is overcome this mechanism by designing developing novel analogues. We design...

The synthesis and characterization of dinuclear ruthenium polypyridyl complexes based on the bridging ligands 1,3-bis-(5’-(pyridin-2’’-yl)-1’H-1’,2’,4’-triaz-3’-yl)-benzene, 1,4-bis-(5’-(pyridin-2’’-yl)-1’H-1’,2’,4’-triaz-3’-yl)-benzene, 2,5-bis-(5’-(pyridin-2’’yl)-1’H-1’,2’,4’-triaz-3’-yl)-thiophene, 2,5-bis-(5’-(pyrazin-2’’-yl)-1’H-1’,2’,4’-triaz3’-yl)-thiophene, and of their mononuclear anal...

Drawing the experience of 5-phenyl- and 5-pyridyltetrazoles, it was shown that classical nitration-reduction methods in combination with typical alkylation reactions tetrazole derivatives can be used to obtain multitopic polynuclear tetrazole-containing ligands. Methods for preparation a number previously undescribed derivatives, including those combining both pyridine rings molecule, have been...